Berberine-gut microbiota interactions based on CiteSpace: current research status and hotspots

Background The gut microbiota modulates host metabolic and immune homeostasis through host-microbiota interactions and microbial metabolites. Berberine (BBR), the primary active constituent of Coptis chinensis , has been shown to ameliorate host metabolic disorders by remodeling the gut microbial community. However, systematic reviews remain relatively scarce regarding the mechanisms underlying BBR-gut microbiota interactions. Methods Therefore, we conducted a bibliometric analysis of 426 articles retrieved from the Web of Science Core Collection (WOSCC) and the China National Knowledge Infrastructure (CNKI) database (January 1, 2005–January 31, 2025) using CiteSpace. Analyses included publication trends, country/author collaboration networks, keyword co-occurrence and burst detection, and document co-citation analysis. Results The results revealed a steady increase in annual publications, with China contributing the majority of studies. Author collaboration networks indicated limited integration among research groups. Keyword analysis identified key research clusters such as diabetes, inflammation, bile acid metabolism, and colorectal cancer. Chinese studies placed greater emphasis on disease applications, whereas English-language articles tended to focus on mechanistic insights. Emerging research hotspots include depression, fecal microbiota transplantation, bile acids, and ulcerative colitis. Co-citation analysis highlighted two foundational themes: microbial metabolites and metabolic-immune crosstalk. Discussion This bibliometric study systematically outlines the research landscape of berberine-gut microbiota interactions, highlighting emerging frontiers such as neuro-microbial crosstalk, fecal microbiota transplantation (FMT) -based combination therapies, and metabolic-immune mechanisms. The findings provide valuable references for identifying research trends, fostering collaboration, and guiding future investigations in this field.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-03-16
DOI
https://doi.org/10.3389/fmicb.2026.1751887
Primary Topic
Berberine and alkaloids research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Berberine-gut microbiota interactions based on CiteSpace: current research status and hotspots

Yuanyong Yang, S. J. Tian, Xiangchun Shen, Yan Chen et al.
Frontiers in Microbiology
Berberine and alkaloids research
article

Berberine-gut microbiota interactions based on CiteSpace: current research status and hotspots

Yuanyong Yang, S. J. Tian, Xiangchun Shen, Yan Chen, Ling Tao, Tao Chen, Fangfang Fan
article en

Abstract

Background The gut microbiota modulates host metabolic and immune homeostasis through host-microbiota interactions and microbial metabolites. Berberine (BBR), the primary active constituent of Coptis chinensis , has been shown to ameliorate host metabolic disorders by remodeling the gut microbial community. However, systematic reviews remain relatively scarce regarding the mechanisms underlying BBR-gut microbiota interactions. Methods Therefore, we conducted a bibliometric analysis of 426 articles retrieved from the Web of Science Core Collection (WOSCC) and the China National Knowledge Infrastructure (CNKI) database (January 1, 2005–January 31, 2025) using CiteSpace. Analyses included publication trends, country/author collaboration networks, keyword co-occurrence and burst detection, and document co-citation analysis. Results The results revealed a steady increase in annual publications, with China contributing the majority of studies. Author collaboration networks indicated limited integration among research groups. Keyword analysis identified key research clusters such as diabetes, inflammation, bile acid metabolism, and colorectal cancer. Chinese studies placed greater emphasis on disease applications, whereas English-language articles tended to focus on mechanistic insights. Emerging research hotspots include depression, fecal microbiota transplantation, bile acids, and ulcerative colitis. Co-citation analysis highlighted two foundational themes: microbial metabolites and metabolic-immune crosstalk. Discussion This bibliometric study systematically outlines the research landscape of berberine-gut microbiota interactions, highlighting emerging frontiers such as neuro-microbial crosstalk, fecal microbiota transplantation (FMT) -based combination therapies, and metabolic-immune mechanisms. The findings provide valuable references for identifying research trends, fostering collaboration, and guiding future investigations in this field.

Frontiers in MicrobiologyVol. 17
Guiyang Medical University (CN), Affiliated Hospital of Guizhou Medical University (CN)
Health Commission of Guizhou Province, National Natural Science Foundation of China, Guizhou Medical University
Industry, innovation and infrastructure
Openalex Percentile: Top 20%
Berberine and alkaloids research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.